Last reviewed · How we verify
Triamcinolone Acetonide- Indomethacin-Cryotherapy-Casting
This is a multimodal treatment combining corticosteroid anti-inflammation (triamcinolone acetonide), nonsteroidal anti-inflammatory action (indomethacin), localized tissue destruction (cryotherapy), and mechanical immobilization (casting) for musculoskeletal or orthopedic conditions.
This is a multimodal treatment combining corticosteroid anti-inflammation (triamcinolone acetonide), nonsteroidal anti-inflammatory action (indomethacin), localized tissue destruction (cryotherapy), and mechanical immobilization (casting) for musculoskeletal or orthopedic conditions. Used for Musculoskeletal inflammatory conditions requiring local anti-inflammatory and immobilization therapy.
At a glance
| Generic name | Triamcinolone Acetonide- Indomethacin-Cryotherapy-Casting |
|---|---|
| Sponsor | Azad University of Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Orthopedics/Rheumatology |
| Phase | FDA-approved |
Mechanism of action
Triamcinolone acetonide reduces inflammation via glucocorticoid receptor activation. Indomethacin inhibits prostaglandin synthesis to further suppress inflammation and pain. Cryotherapy induces localized tissue necrosis and reduces metabolic activity in the treated area. Casting provides mechanical stabilization and immobilization to prevent further injury and promote healing.
Approved indications
- Musculoskeletal inflammatory conditions requiring local anti-inflammatory and immobilization therapy
Common side effects
- Local skin irritation or cryotherapy-related tissue damage
- Gastrointestinal effects from indomethacin
- Systemic corticosteroid effects (with repeated use)
- Immobilization-related complications (atrophy, stiffness)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: